Summary of characteristics of synthetic progestogens and indications for usea
| Generation | Progestogen | COCP preparation | Available as POP | Physiological activity | Best formulation for use | |
|---|---|---|---|---|---|---|
| Monophasic | Multiphasic | |||||
| 1st | Medroxyprogesterone | ✓ | ✗ | ✓ | Moderate androgenic | Irregular or missed periods |
| Minor glucocorticoid | ||||||
| Norethisterone | ✓ | ✓ | ✓ | Moderate progestogenic | Menorrhagia, adenomyosis | |
| Mild androgenic | ||||||
| 2nd | Levonorgestrel | ✓ | ✓ | ✓ | Strongly progestogenic | Menorrhagia, adenomyosis |
| Strongly androgenic | ||||||
| 3rd | Desogestrel | ✓ | ✗ | ✓ | Strongly progestogenic | Dysmenorrhoea, endometriosis |
| Norgestimate | ✓ | ✗ | ✗ | Medium progestogenic | Moderate acne | |
| Weakly androgenic | ||||||
| Gestodene | ✓ | ✗ | ✗ | Strongly progestogenic | Dysmenorrhoea | |
| Mildly androgenic | ||||||
| 4th | Drospirenone | ✓ | ✗ | ✗ | Anti-androgenic | Acne, PCOS, PMS |
| Anti-mineralocorticoid | ||||||
| Dienogest | ✗ | ✓ | ✓ | Anti-androgenic | Endometriosis | |
| POP not licensed for contraceptive purposes in UK | ||||||
| Nomegestrol | ✓ | ✗ | ✗ | Targeted anti-oestrogenic at endometrium | Menorrhagia, PCOS, PMS | |
| Partial anti-androgenic | ||||||
↵a The indications for use apply regardless of whether the progestogen is prescribed in combination with oestrogen or if available, as the POP. COCP = combined oral contraceptive pill. PCOS = polycystic ovarian syndrome. PMS = pre-menstrual syndrome. POP = progestogen-only pill.